Kingwell Bronwyn A, Ahimastos Anna A
Baker Heart Research Institute, Melbourne , Australia.
Adv Cardiol. 2007;44:125-138. doi: 10.1159/000096725.
Large artery stiffening may be both a cause and a consequence of atherosclerosis and is independently related to coronary outcome. This relationship is likely to be causal given the unfavourable effect of large artery stiffening on coronary hemodynamics. There is clear experimental and clinical evidence that large artery stiffening promotes myocardial ischemia secondary to central pulse pressure elevation. Many agents commonly used to treat ischemic heart disease symptoms also reduce large artery stiffness, through both functional and structural mechanisms. Such effects likely contribute to the anti-ischemic actions of these drugs. However, it remains to be elucidated whether agents specifically targeted to reduce large artery stiffness provide ischemic protection in the setting of coronary disease.
大动脉僵硬度增加可能既是动脉粥样硬化的原因,也是其结果,并且与冠状动脉疾病的预后独立相关。鉴于大动脉僵硬度增加对冠状动脉血流动力学的不利影响,这种关系可能是因果关系。有明确的实验和临床证据表明,大动脉僵硬度增加会导致中心脉压升高继发心肌缺血。许多常用于治疗缺血性心脏病症状的药物,通过功能和结构机制,也能降低大动脉僵硬度。这些作用可能有助于这些药物的抗缺血作用。然而,专门针对降低大动脉僵硬度的药物在冠心病情况下是否能提供缺血保护仍有待阐明。